[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"iga-nephropathy-severity-in-kidney-transplantation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:iga-nephropathy-severity-in-kidney-transplantation":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":5},"100457274","study-of-the-link-between-complement-activation-and-iga-nephropathy-severity-100457274",false,"NCT05234463","Study of the Link Between Complement Activation and IgA Nephropathy Severity","ICONE","Inclusion Criteria:\n\n* Adult patients, male or female, with a biopsy proven IgA nephropathy.\n* Primitive and secondary forms can be included\n* Regardless of the date of diagnosis and the level of kidney function\n* With or without past of kidney transplantation\n* Followed in the Nephrology Department, Strasbourg University Hospital\n* Signed informed consent\n\nExclusion Criteria:\n\n* Active or recent infectious or inflammatory syndrome (\\\u003C2 months), recent vaccination (\\\u003C2 months), ongoing acute humoral rejection treatment, treatment with plasma exchanges (\\\u003C2 months), current treatment with complement inhibitors\n* Impossibility of giving informed information (emergency situation, difficulties in understanding, etc.)\n* Subject under safeguard of justice, guardianship or curatorship","ALL","18 Years",{"count":19,"type":20},400,"ESTIMATED","OBSERVATIONAL","ICONE study (IgA Complement and NEphropathy is a prospective monocentric observational study.\n\nThe main objective is to evaluate the relevance of complement activation as a biomarker of disease severity and progression in patients with a biopsy proven IgAN.",[24],"IgA Nephropathy Severity in Kidney Transplantation","RECRUITING","2026-08-18",{"date":28,"type":29},"2026-08-19","ACTUAL",{"date":31,"type":29},"2022-05-09",{"date":33,"type":20},"2027-05-01",{"name":35,"class":36},"University Hospital, Strasbourg, France","OTHER"]